These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 9036113

  • 1. [19-year-old patient with thromboembolism caused by oral contraception].
    Pihusch R, de Coutre P, Salat C, Göhring P, Poley S, Hiller E.
    Internist (Berl); 1996 Nov; 37(11):1163-6. PubMed ID: 9036113
    [No Abstract] [Full Text] [Related]

  • 2. [Proper education for the patient! Risk of thromboembolism with oral contraception].
    Wenderlein JM.
    MMW Fortschr Med; 2000 Feb 17; 142(7):38-9. PubMed ID: 10832333
    [No Abstract] [Full Text] [Related]

  • 3. Family history and risk of venous thromboembolism with oral contraception. Family history is important tool.
    Vandenbroucke JP, van der M eer FJ, Helmerhorst FM, Rosendaal FR.
    BMJ; 2001 Sep 29; 323(7315):752. PubMed ID: 11675729
    [No Abstract] [Full Text] [Related]

  • 4. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
    Schambeck CM, Schwender S, Haubitz I, Geisen UE, Grossmann RE, Keller F.
    Thromb Haemost; 1997 Dec 29; 78(6):1480-3. PubMed ID: 9423798
    [Abstract] [Full Text] [Related]

  • 5. [Hormones and hemostasis].
    Winkler UH.
    Geburtshilfe Frauenheilkd; 1994 Mar 29; 54(3):M39-42. PubMed ID: 8188004
    [No Abstract] [Full Text] [Related]

  • 6. [A new test system for evaluating the risk of thromboembolism in the use of hormonal contraceptives].
    Pechlaner C, Kunz F, Tabarelli M, Sölder E, Zwierzina WD, Reitsamer R, Koch R.
    Gynakol Rundsch; 1989 Mar 29; 29 Suppl 2():312-4. PubMed ID: 2613036
    [No Abstract] [Full Text] [Related]

  • 7. [Contraception in risk patients. Discussion].
    Detering K, Hartmann E.
    Med Welt; 1980 Dec 05; 31(49):1805-6. PubMed ID: 7207122
    [No Abstract] [Full Text] [Related]

  • 8. Oral contraceptives and hypercoagulation.
    Petitti DB.
    Clin Adv Hematol Oncol; 2006 Nov 05; 4(11):813-5. PubMed ID: 17143250
    [No Abstract] [Full Text] [Related]

  • 9. [APC (activated protein C) resistance and oral contraceptives].
    Kreis I, Weiss T, Rabe TN, Ziegler R, Nawroth PP.
    Geburtshilfe Frauenheilkd; 1996 May 05; 56(5):231-3. PubMed ID: 8768059
    [Abstract] [Full Text] [Related]

  • 10. [Hormonal contraception--thromboembolic disorders and surgical risk (author's transl)].
    Göretzlehner G, Frick G, Frick U.
    Zentralbl Chir; 1976 May 05; 101(18):1103-11. PubMed ID: 983453
    [Abstract] [Full Text] [Related]

  • 11. [Oral contraceptives and thromboembolism (author's transl)].
    Sato K, Ogino M, Nakabayashi M, Sakamoto S.
    Kokyu To Junkan; 1978 Mar 05; 26(3):212-20. PubMed ID: 349637
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Consensus statement regarding indications for Leiden (FVL-factor V Leiden) mutation determination when recommending combined hormonal contraception or hormone replacement therapy].
    Cibula D, Kvasnicka J, Salaj P, Vorlová Z, Unzeitig V, Zivný J.
    Vnitr Lek; 2003 Jun 05; 49(6):502. PubMed ID: 14503480
    [No Abstract] [Full Text] [Related]

  • 15. [Risk of thromboembolism in contraception and hormone substitution: an update and recommendations].
    van den Brûle F, Gaspard U.
    J Pharm Belg; 2004 Jun 05; 59(1):38-40. PubMed ID: 15129579
    [Abstract] [Full Text] [Related]

  • 16. Role of family history in identifying women with thrombophilia and higher risk of venous thromboembolism during oral contraception.
    Cosmi B, Legnani C, Bernardi F, Coccheri S, Palareti G.
    Arch Intern Med; 2003 May 12; 163(9):1105-9. PubMed ID: 12742811
    [Abstract] [Full Text] [Related]

  • 17. [Summary of the practice guideline 'Hormonal contraception' (second revision) from the Dutch College of General Practitioners].
    Siemons GH.
    Ned Tijdschr Geneeskd; 2004 Oct 02; 148(40):1999. PubMed ID: 15524140
    [No Abstract] [Full Text] [Related]

  • 18. Does use of hormonal contraceptives among women with thrombogenic mutations increase their risk of venous thromboembolism? A systematic review.
    Mohllajee AP, Curtis KM, Martins SL, Peterson HB.
    Contraception; 2006 Feb 02; 73(2):166-78. PubMed ID: 16413847
    [Abstract] [Full Text] [Related]

  • 19. [Estrogen-progestin contraception and cardiovascular diseases: the end of polemics on the third generation].
    Jamin C.
    Contracept Fertil Sex; 1998 May 02; 26(5):331-7. PubMed ID: 9648376
    [No Abstract] [Full Text] [Related]

  • 20. [Hormonal contraception and risk of venous thromboembolism: When to ask for an assessment of hemostasis? Which parameters?].
    Plu-Bureau G, Horellou MH, Gompel A, Conard J.
    Gynecol Obstet Fertil; 2008 Apr 02; 36(4):448-54. PubMed ID: 18424163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.